Association of blood group B and of rare variants affecting immune system with multisystem inflammatory syndrome in children in an Italian cohort

Background: Multisystem inflammatory syndrome in children (MIS-C) is an uncommon delayed complication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children, whose cause remains unknown. The aim of this study was to investigate the role of genetic predisposition to COVID-19 and dysregulated inflammatory response in the development of MIS-C in Italian children. Methods: = 266). Results: = 0.007). A total of 49 rare damaging variants, 4 classified as pathogenic, were prioritized in 39 immune-related genes; all patients harbored at least one variant. Conclusions: These results not only support a role of blood group B as a risk factor for MIS-C development in children with COVID-19, possibly through modulation of the coagulability and microvascular dysfunction, but also support an immune-genetic basis for this condition.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-04-10
DOI
https://doi.org/10.3389/fimmu.2026.1777516
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of blood group B and of rare variants affecting immune system with multisystem inflammatory syndrome in children in an Italian cohort

Giovanni Filocamo, Samantha Bosis, Francesca Minoia, Luca Valenti et al.
Frontiers in Immunology
Blood groups and transfusion
article

Association of blood group B and of rare variants affecting immune system with multisystem inflammatory syndrome in children in an Italian cohort

Giovanni Filocamo, Samantha Bosis, Francesca Minoia, Luca Valenti, Lucia Augusta Baselli, Giada Di Pietro, Luisa Ronzoni, Lorenzo Miano, F. Malvestiti, Angela Lombardi, Daniele Prati, Veronica Torcianti
article en

Abstract

Background: Multisystem inflammatory syndrome in children (MIS-C) is an uncommon delayed complication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children, whose cause remains unknown. The aim of this study was to investigate the role of genetic predisposition to COVID-19 and dysregulated inflammatory response in the development of MIS-C in Italian children. Methods: = 266). Results: = 0.007). A total of 49 rare damaging variants, 4 classified as pathogenic, were prioritized in 39 immune-related genes; all patients harbored at least one variant. Conclusions: These results not only support a role of blood group B as a risk factor for MIS-C development in children with COVID-19, possibly through modulation of the coagulability and microvascular dysfunction, but also support an immune-genetic basis for this condition.

Frontiers in ImmunologyVol. 17
University of Milan (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
Ministero della Salute, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Ministero dell'Università e della Ricerca, Horizon 2020
Good health and well-being
Openalex Percentile: Top 24%
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.